Clinical Study
Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey
Table 1
Etiology of the diagnosed central neuropathic pain. Neuropathies within the patient cohort were grouped by an inflammatory origin (n = 43) or a trauma of the central nervous system (n = 49). Note that fibromyalgia patients (n = 32) are not listed.
|